| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 42,037 | 37,752 | 43,750 | 48,710 | | Cost of Revenue | 25,405 | 23,776 | 26,339 | 29,563 | | | Gross Profit | 16,632 | 13,976 | 17,411 | 19,147 | | | Operating Expenses | | Research Development | 1,850 | 1,697 | 1,835 | 2,281 | | Selling General and Administrative | 15,046 | 15,038 | 16,094 | 16,414 | | Non Recurring | (601) | 4,823 | 4,484 | 32,278 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 337 | (7,582) | (5,002) | (31,826) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (97) | 542 | (64) | 90 | | Earnings Before Interest And Taxes | 240 | (7,040) | (5,066) | (31,736) | | Interest Expense | 474 | 964 | 1,225 | 46 | | Income Before Tax | (234) | (8,004) | (6,291) | (31,782) | | Income Tax Expense | (923) | (606) | (1,953) | (11,108) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 689 | (7,398) | (4,338) | (20,674) | | | Non-recurring Events | | Discontinued Operations | 8 | (1,148) | (136) | (686) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 697 | (8,546) | (4,474) | (21,360) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $697 | ($8,546) | ($4,474) | ($21,360) |
|
0.03% Nasdaq 
Income Statement
